Emerging role of apelin as a therapeutic target in cancer: a patent review.
about
Serum levels of resistin, adiponectin, and apelin in gastroesophageal cancer patients.Tumor apelin, not serum apelin, is associated with the clinical features and prognosis of gastric cancerEvaluation of adipokines: apelin, visfatin, and resistin in children with atopic dermatitis.Jagged-1/Notch3 signaling transduction pathway is involved in apelin-13-induced vascular smooth muscle cells proliferation.Apelin levels are higher in obese patients with endometrial cancer.Apelin-13 Prevents the Delayed Neuropathy Induced by Tri-ortho-cresyl Phosphate Through Regulation the Autophagy Flux in Hens
P2860
Emerging role of apelin as a therapeutic target in cancer: a patent review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Emerging role of apelin as a therapeutic target in cancer: a patent review.
@en
Emerging role of apelin as a therapeutic target in cancer: a patent review.
@nl
type
label
Emerging role of apelin as a therapeutic target in cancer: a patent review.
@en
Emerging role of apelin as a therapeutic target in cancer: a patent review.
@nl
prefLabel
Emerging role of apelin as a therapeutic target in cancer: a patent review.
@en
Emerging role of apelin as a therapeutic target in cancer: a patent review.
@nl
P2093
P1476
Emerging role of apelin as a therapeutic target in cancer: a patent review.
@en
P2093
Clifton A Baile
Thomas Kasser
William Warren
P304
P356
10.2174/157489211796957856
P577
2011-09-01T00:00:00Z